Deutsche Bank has launched its Global Fund Supporters ETF on the London Stock Exchange, investing in companies involved in the prevention and treatment of disease.
The ETF, first unveiled on the Deutsche Boerse in December last year, tracks a Dow Jones index compiled of the 50 largest companies that support the mission of the Global Fund. The Global Fund is dedicated to the prevention and treatment of HIV/Aids, tuberculosis and malaria. Since its establishment in 2002, the funding agency has committed over $21bn across 144 countries towards disease prevention, treatment and care programmes. The ETF is also physically replicated, making it an anomaly in db x-trackers swap-based platform of ETFs. Using a direct investment approach ensures that inv...
To continue reading this article...
Join Professional Adviser for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes
